Skip to main content

Strict Liability Claims Against Pelvic Mesh Manufacturer

Strict Liability Claims Against Pelvic Mesh Manufacturer

Strict Liability Claims Against Pelvic Mesh Manufacturer

Introduction

The U.S. District Judge Michael Baylson of the Eastern District of Pennsylvania allowed strict liability claims to proceed against Coloplast Corp. in a pelvic mesh case.

The lawsuit was filed by a woman and her husband, against the pelvic mesh manufacturer, in 2018 over its allegedly defective device. The plaintiffs raised eight claims, including three based on strict liability.

According to a motion filed, Coloplast attempted to extend protections provided to the makers of prescription medical devices under comment K to Section 402 of the Restatement (Second) of Torts, citing the 2006 Pennsylvania Supreme Court decision in Creazzo v. Medtronic. But in Jan. 17 order, the judge denied the company’s motion to dismiss for failure to state a claim on the strict liability issues. The judge also noted that the U.S. Food and Drug Administration initially approved the device, but ordered the company to stop selling it in April 2019.

The Pennsylvania Supreme Court advised the judges to not make categorical decisions about products concerning liability, without a strong record on the policy issues that should inform a common-law analysis of whether to allow these claims.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!